Work

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85

Year: 1998

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Radiotherapy and Oncology

DOI: 10.1016/s0167-8140(97)00220-x

Authors: Jens Overgaard, Hanne Sand Hansen, Marie Overgaard, Lars Bastholt, Anne Berthelsen, Lena Specht, Birgit Lindeløv, Karsten Jørgensen

Institutions: Aarhus University Hospital, Danish Cancer Society, Rigshospitalet, Odense University Hospital, Herlev Hospital

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2022342238

FWCI: 14.81

Cites: 44

Cited by: 584

Related to: 10